Management of Painful Diabetic Neuropathy
- 1 January 2001
- journal article
- review article
- Published by Springer Science and Business Media LLC in Drugs & Aging
- Vol. 18 (10), 737-749
- https://doi.org/10.2165/00002512-200118100-00003
Abstract
No abstract availableKeywords
This publication has 84 references indexed in Scilit:
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- Tolrestat in the Primary Prevention of Diabetic NeuropathyDiabetes Care, 1995
- Transdermal clonidine compared to placebo in painful diabetic neuropathy using a two-stage ‘enriched enrollment’ designPain, 1995
- Pharmacology of Antidepressants—Characteristics of the Ideal DrugMayo Clinic Proceedings, 1994
- Skin Blood Flow and Current Perception in Pentoxifylline-Treated Diabetic NeuropathyAngiology, 1992
- Studies on the spinal interaction of morphine and the NMDA antagonist MK-801 on the hyperesthesia observed in a rat model of sciatic mononeuropathyNeuroscience Letters, 1992
- Topical Capsaicin in Painful Diabetic Neuropathy: Effect on Sensory FunctionDiabetes Care, 1992
- Intravenous lidocaine infusion — a new treatment of chronic painful diabetic neuropathy?Pain, 1987
- The Influence of Pyridoxine in Diabetic Peripheral NeuropathyDiabetes Care, 1981
- Symptomatic treatment of peripheral diabetic neuropathy with carbamazepine (Tegretol®): Double blind crossover trialDiabetologia, 1969